Alfuzosin Hydrochloride NDC 71335-2578

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-2578Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-2578Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-2578-1	71335257801	30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-2578-1)Marketed from Feb 6, 2025
71335-2578-2	71335257802	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-2578-2)Marketed from Feb 6, 2025
71335-2578-3	71335257803	90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-2578-3)Marketed from Feb 6, 2025
71335-2578-4	71335257804	120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-2578-4)Marketed from Feb 6, 2025
71335-2578-5	71335257805	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-2578-5)Marketed from Feb 6, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alfuzosin Hydrochloride
Generic name (nonproprietary): alfuzosin hydrochloride
Active ingredients: Alfuzosin hydrochloride — 10 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 079060
Marketing start: Aug 30, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Antagonists (Mechanism)
Identifiers: Product ID 71335-2578_7ce6f1ee-cf32-445d-a682-b01823587446SPL ID 7ce6f1ee-cf32-445d-a682-b01823587446SPL set ID 37e89394-af6e-4700-bfa8-2effba1a286bRxCUI 861132UNII 75046A1XTN
Pharmacologic class: alpha-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335257801 followed by a unit qualifier and the quantity

Package 71335-2578-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 079060

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 079060
Product	Strength	Form · route	Labeler	Product NDC
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Northwind Health Company, LLC	51655-087
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	65862-249
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	84386-153
Alfuzosin Hydrochloride	Alfuzosin hydrochloride 10 mg/1	Tablet, Film coated, Extended releaseOral	Rising Pharma Holdings, Inc.	57237-114